Opus Genetics (IRD) Gains from Investment Securities (2018 - 2020)
Opus Genetics' (IRD) quarterly Gains from Investment Securities came in at -$100637.0 in Q3 2020, up 58.56% year-on-year from -$63468.7 in Q4 2019, and down 159.65% on a QoQ basis from $168702.0 in Q2 2020.
Opus Genetics (IRD) Gains from Investment Securities (2018 - 2020) Analysis & Trends
Opus Genetics (IRD) has 3 years of Gains from Investment Securities data on file, last reported at -$100637.0 in Q3 2020.
- On a quarterly basis, Gains from Investment Securities rose 58.56% year-over-year to -$100637.0 in Q3 2020; TTM through Sep 2020 was $44302.0, a 101.11% increase from a year earlier, with the FY2019 full-year figure at -$2.3 million, up 59.14% from the prior year.
- Gains from Investment Securities for Q3 2020 stood at -$100637.0, down from $168702.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for IRD reached as high as $710065.0 in Q3 2018 and fell as low as -$3.4 million in Q1 2018.
- Historically, Gains from Investment Securities has averaged -$698678.3 across 3 years, with a median of -$242860.0 in 2019.
- Across the five-year window, Gains from Investment Securities sank 134.2% in 2019 and jumped 139.46% in 2020, its largest moves.
- Year by year, Gains from Investment Securities stood at -$1.8 million in 2018, then soared by 95.42% to -$82155.0 in 2019, then retreated by 22.5% to -$100637.0 in 2020.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were -$100637.0 in Q3 2020, $168702.0 in Q2 2020, and $58392.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -100,637.00 |
| Sep 30, 2020 | -100,637.00 |
| Jun 30, 2020 | 168,702.00 |
| Jun 30, 2020 | 168,702.00 |
| Mar 31, 2020 | 58,392.00 |
| Mar 31, 2020 | 58,392.00 |
| Dec 31, 2019 | -82,155.00 |
| Dec 31, 2019 | -82,155.00 |
| Sep 30, 2019 | -242,860.00 |
| Sep 30, 2019 | -242,860.00 |
| Jun 30, 2019 | -427,483.00 |
| Jun 30, 2019 | -427,483.00 |
| Mar 31, 2019 | -1.51 Mn |
| Mar 31, 2019 | -1.51 Mn |
| Dec 31, 2018 | -1.79 Mn |
| Dec 31, 2018 | -1.79 Mn |
| Sep 30, 2018 | 710,065.00 |
| Sep 30, 2018 | 710,065.00 |
| Jun 30, 2018 | -1.10 Mn |
| Jun 30, 2018 | -1.10 Mn |